Chair: Jonathan Barker, President, UK
Members: Craig Leonardi, Vice President & President-Elect, USA Bruce Strober, Treasurer/Secretary, USA Christy Langan, CEO, USA
Chair: Bruce Strober, USA
Members: Jonathan Barker, UK Robert Holland III, USA Christy Langan, USA
Chair: Robert Holland III, USA
Members: Jonathan Barker, UK Bruce Strober, USA Craig Leonardi, USA Christy Langan, USA
Members: Claudia de la Cruz, Chile Robert Holland III, USA Craig Leonardi, USA Christy Langan, USA
Program Committees & Working Groups
Chair: Bruce Strober, USA Co-chair: Lone Skov, Denmark Members: Matthias Augustin, Germany Andy Blauvelt, USA Cristina Echeverria, Argentina Marcus Schmitt-Egenolf, Sweden
Learn more about the disease severity project
Chair: Johann Gudjonsson, USA Co-chair: Nicole Ward, USA
Members: Siew Eng Choon, Malaysia Matthias Maskin, Argentina Tiago Torres, Portugal
Fellowship program advisory committee
Chair: Lars Iversen, Denmark Co-chair: Elise Kleyn, UK Members: Marc Bourcier, Canada Kelly Cordoro, USA Colin Theng, Singapore Fernando Valenzuela, Chile Omid Zargari, Iran
Learn more about the Fellowship program
Chair: Alexander Navarini, Switzerland Co-chair: Joel Gelfand, USA Members: April Armstrong, USA Christophe Hsu, Switzerland Andrea Chiricozzi, Italy Vahid Diamei, Switzerland Mohamed El-Komy, Egypt
now available COVID-19 Psoriasis Resource Center Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve explore now
Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve
Latest news Video Series on IPC’s Psoriasis Severity ReclassificationMarch 30, 2021Learn how psoriasis severity is currently measured and why a change is necessary, how IPC organized the Delphi process that was used to redefine severity classification, implications and effects the output has on psoriasis treatment providers and psoriasis patients, and ultimately how patients will benefit from this endeavor. Janssen Phase-3 TREMFYA® Clinical TrialMarch 29, 2021Janssen Pharmaceutical Companies of Johnson & Johnson published the long-term data of the third phase of the DISCOVER-2a study. Sun Pharma Phase-3 ILUMYA® Clinical TrialMarch 28, 2021Sun Pharmaceutical Industries Inc. announces results from their five-year Phase-3 efficacy and safety clinical trial for ILUMYA®(tildrakizumab-asmn) based on a pooled analysis of the ReSURFACE 1 and ReSURFACE 2 extension. Update on PsoProtect Registry DataMarch 17, 2021Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1002 cases. More News